VanEck Biotech ETF (BBH)
Price:
197.28 USD
( + 0.48 USD)
Your position:
0 USD
ACTION PANEL
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
ProShares UltraShort Nasdaq Biotechnology
VALUE SCORE:
9
2nd position
SuRo Capital Corp.
VALUE SCORE:
13
The best
SuRo Capital Corp. 6.00% Notes due 2026
VALUE SCORE:
13
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
NEWS
VanEck Biotech ETF (NASDAQ:BBH) & Compass Diversified (NYSE:CODI) Financial Survey
defenseworld.net
2026-02-12 02:32:51VanEck Biotech ETF (NASDAQ: BBH - Get Free Report) and Compass Diversified (NYSE: CODI - Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability. Earnings and Valuation This table compares
BBH: Mature Biotech Exposure, But Limited Growth Ahead
seekingalpha.com
2026-01-21 16:26:22BBH: Mature Biotech Exposure, But Limited Growth Ahead
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2026-01-06 07:21:10Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, 2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
businesswire.com
2025-12-19 20:24:00NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2025 annual distributions per share for its VanEck equity exchange-traded funds.
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH
defenseworld.net
2025-11-23 03:55:07Boston Research and Management Inc. lessened its holdings in shares of VanEck Biotech ETF (NASDAQ: BBH) by 4.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,812 shares of the company's stock after selling 499 shares during the quarter.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-11-04 07:21:11The VanEck Biotech ETF (BBH) was launched on December 20, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
AMG and Brown Brothers Harriman Announce Strategic Collaboration
globenewswire.com
2025-10-01 06:59:00BBH and AMG to Partner in Developing New Products for the U.S. Wealth Marketplace, Leveraging BBH's Industry-Leading Structured and Alternative Credit Expertise and AMG's Proven Product Development and Distribution Capabilities
Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz
youtube.com
2025-09-03 15:32:42Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
seekingalpha.com
2025-09-01 08:03:56Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators with strong cash reserves, while IBB provides broader diversification but dilutes exposure to top players. Despite optimism for sector catalysts, both BBH and IBB have underperformed historically and now trade at the upper end of their price ranges.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-09-01 07:21:26Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, 2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-06-30 07:21:16Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
BBH: Fear Of Price Controls Is Not The Problem
seekingalpha.com
2025-05-14 09:00:00The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to skepticism from newly appointed officials, impacting funding and development. The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-04-29 07:20:51Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-02-25 07:20:24Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2024-12-24 07:20:39Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
businesswire.com
2024-12-20 20:56:00NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).
No data to display
VanEck Biotech ETF (NASDAQ:BBH) & Compass Diversified (NYSE:CODI) Financial Survey
defenseworld.net
2026-02-12 02:32:51VanEck Biotech ETF (NASDAQ: BBH - Get Free Report) and Compass Diversified (NYSE: CODI - Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability. Earnings and Valuation This table compares
BBH: Mature Biotech Exposure, But Limited Growth Ahead
seekingalpha.com
2026-01-21 16:26:22BBH: Mature Biotech Exposure, But Limited Growth Ahead
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2026-01-06 07:21:10Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, 2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
businesswire.com
2025-12-19 20:24:00NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2025 annual distributions per share for its VanEck equity exchange-traded funds.
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH
defenseworld.net
2025-11-23 03:55:07Boston Research and Management Inc. lessened its holdings in shares of VanEck Biotech ETF (NASDAQ: BBH) by 4.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,812 shares of the company's stock after selling 499 shares during the quarter.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-11-04 07:21:11The VanEck Biotech ETF (BBH) was launched on December 20, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
AMG and Brown Brothers Harriman Announce Strategic Collaboration
globenewswire.com
2025-10-01 06:59:00BBH and AMG to Partner in Developing New Products for the U.S. Wealth Marketplace, Leveraging BBH's Industry-Leading Structured and Alternative Credit Expertise and AMG's Proven Product Development and Distribution Capabilities
Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz
youtube.com
2025-09-03 15:32:42Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
seekingalpha.com
2025-09-01 08:03:56Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators with strong cash reserves, while IBB provides broader diversification but dilutes exposure to top players. Despite optimism for sector catalysts, both BBH and IBB have underperformed historically and now trade at the upper end of their price ranges.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-09-01 07:21:26Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, 2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-06-30 07:21:16Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
BBH: Fear Of Price Controls Is Not The Problem
seekingalpha.com
2025-05-14 09:00:00The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to skepticism from newly appointed officials, impacting funding and development. The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-04-29 07:20:51Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2025-02-25 07:20:24Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
zacks.com
2024-12-24 07:20:39Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
businesswire.com
2024-12-20 20:56:00NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).